Rome, Nov 17. (Adnkronos Health) – “Phenylketonuria is a genetic disease caused by the mutation of a gene that leads to a deficiency of a very important enzyme – phenylalanine hydroxylase – which converts phenylalanine into byproducts, causing an accumulation of this essential amino acid. It is a rare disease, but the incidence in newborns is about 1 case per 10,000 births in Europe, and in Italy it is even slightly higher. High levels of phenylalanine in the blood become toxic and compromise neurological, physical, and psychomotor development. To maintain the concentration of this essential amino acid at physiological, or at least adequate, levels, historically, diet therapy has been used, which obviously remains the cornerstone of the treatment for this disease. Recently, other therapeutic perspectives have also emerged on the therapeutic scene.” Thus, Graziella Cefalo, pediatrician, head of Rare Diseases Ss, Asst Santi Paolo e Carlo of Milan, explains the impact of new therapeutic approaches such as pegvaliase in the disease. The drug is already authorized for the treatment of the pathology and has recently received an extension of its therapeutic indications from the European Commission (Ema) to include patients with phenylketonuria (Pku) aged 12 years or older. (VIDEO)
Being an accumulation disease, “early diagnosis is essential to start a low-phenylalanine diet therapy – emphasizes the expert – Starting effective therapy in pre-adolescents or adolescents leads to greater compliance with therapy, controls, and a better life.”
“The new therapies – continues Cefalo – allow patients with phenylketonuria to maintain adequate levels of this essential amino acid, even abandoning the diet which, however, has a significant impact on their quality of life. The fact that we will soon have the opportunity to carry out this type of therapy also in adolescent patients, i.e., from 12 years of age upwards, will allow, I think, and some data have already confirmed this, for greater adherence to dietary therapy and also to drug therapy. When phenylalanine levels in the blood are adequate, the patients themselves tell us that they feel much better, that they perform better in their studies, at work, and also in relationships with others; they feel less anxious, experience fewer concentration difficulties, and have much more desire to live their lives fully and make plans.”